83 related articles for article (PubMed ID: 22435140)
21. Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model.
Wang K; Zhou Z; Zhang M; Fan L; Forudi F; Zhou X; Qu W; Lincoff AM; Schmidt AM; Topol EJ; Penn MS
J Pharmacol Exp Ther; 2006 Apr; 317(1):37-43. PubMed ID: 16368901
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Shen L
J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
[TBL] [Abstract][Full Text] [Related]
23. Pioglitazone suppresses advanced glycation end product-induced expression of plasminogen activator inhibitor-1 in vascular smooth muscle cells.
Yuan X; Liu N
J Genet Genomics; 2011 May; 38(5):193-200. PubMed ID: 21621740
[TBL] [Abstract][Full Text] [Related]
24. Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Biochem Biophys Res Commun; 2009 Jul; 385(2):269-72. PubMed ID: 19460355
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation.
Zhang HL; Gu ZL; Savitz SI; Han F; Fukunaga K; Qin ZH
J Neurosci Res; 2008 Apr; 86(5):1132-41. PubMed ID: 18074385
[TBL] [Abstract][Full Text] [Related]
26. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
Yu X; Li C; Li X; Cai L
Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
[TBL] [Abstract][Full Text] [Related]
27. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
28. Metabolite control of angiogenesis: angiogenic effect of citrate.
Binu S; Soumya SJ; Sudhakaran PR
J Physiol Biochem; 2013 Sep; 69(3):383-95. PubMed ID: 23161184
[TBL] [Abstract][Full Text] [Related]
29. Damage to vascular endothelial cells by high insulin levels is associated with increased expression of ChemR23, and attenuated by PPAR-gamma agonist, rosiglitazone.
Hao F; Mu JW; Zhang HJ; Kuang HY; Yu QX; Bai MM; Meng P
Neuro Endocrinol Lett; 2015; 36(1):59-66. PubMed ID: 25789586
[TBL] [Abstract][Full Text] [Related]
30. The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules.
Kunt T; Forst T; Harzer O; Buchert G; Pfützner A; Löbig M; Zschäbitz A; Stofft E; Engelbach M; Beyer J
Exp Clin Endocrinol Diabetes; 1998; 106(3):183-8. PubMed ID: 9710358
[TBL] [Abstract][Full Text] [Related]
31. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
[TBL] [Abstract][Full Text] [Related]
32. Role of peroxisome proliferators-activated receptor-gamma in advanced glycation end product-mediated functional loss of voltage-gated potassium channel in rat coronary arteries.
Gao S; Hua B; Liu Q; Liu H; Li W; Li H
BMC Cardiovasc Disord; 2020 Jul; 20(1):337. PubMed ID: 32664860
[TBL] [Abstract][Full Text] [Related]
33. Benzo[a]pyrene inhibits angiogenic factors-induced alphavbeta3 integrin expression, neovasculogenesis, and angiogenesis in human umbilical vein endothelial cells.
Li CH; Cheng YW; Hsu YT; Hsu YJ; Liao PL; Kang JJ
Toxicol Sci; 2010 Dec; 118(2):544-53. PubMed ID: 20876236
[TBL] [Abstract][Full Text] [Related]
34. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin.
Okamoto T; Yamagishi S; Inagaki Y; Amano S; Koga K; Abe R; Takeuchi M; Ohno S; Yoshimura A; Makita Z
FASEB J; 2002 Dec; 16(14):1928-30. PubMed ID: 12368225
[TBL] [Abstract][Full Text] [Related]
35. Paeoniflorin protects HUVECs from AGE-BSA-induced injury via an autophagic pathway by acting on the RAGE.
Chen Y; Du X; Zhou Y; Zhang Y; Yang Y; Liu Z; Liu C; Xie Y
Int J Clin Exp Pathol; 2015; 8(1):53-62. PubMed ID: 25755692
[TBL] [Abstract][Full Text] [Related]
36. Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro.
Hoffmann S; Friedrichs U; Eichler W; Rosenthal A; Wiedemann P
Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):996-1002. PubMed ID: 12483322
[TBL] [Abstract][Full Text] [Related]
37. Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants.
Mamputu JC; Renier G
J Leukoc Biol; 2004 Jun; 75(6):1062-9. PubMed ID: 15020646
[TBL] [Abstract][Full Text] [Related]
38. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
39. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
Hirasawa Y; Sakai T; Ito M; Yoshimura H; Feng Y; Nagamatsu T
Eur J Pharmacol; 2011 Dec; 672(1-3):159-68. PubMed ID: 21989075
[TBL] [Abstract][Full Text] [Related]
40. Modulation of angiogenic factors by ursolic acid.
Kiran MS; Viji RI; Sameer Kumar VB; Sudhakaran PR
Biochem Biophys Res Commun; 2008 Jul; 371(3):556-60. PubMed ID: 18448068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
